Bullish
Henry Schein stock reflects a diversified dental and medical distribution business that adapts to changing procedure volumes and equipment demand in N...
Neutral
Henry Schein, Inc. has announced the election of William K. "Dan" Daniel as the new Independent Chairman of the Board, effective May 21, 2026. He succ...
Henry Schein, Inc. has announced the election of William K. "Dan" Daniel as the independent chairman of its board. This news was published on May 22, ...
Bullish
Henry Schein has appointed William K. "Dan" Daniel as its independent chairman, succeeding Stanley Bergman, who retired after 44 years. Daniel, with a...
Bullish
Henry Schein, Inc. has announced the election of William K. Daniel as its Independent Chairman of the Board, effective May 21, 2026. Daniel succeeds S...
Henry Schein, Inc. announced that William K. “Dan” Daniel has been elected as Independent Chairman of the Board, effective May 21, 2026. This follows ...
Neutral
Henry Schein, Inc. announced the election of William K. “Dan” Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds...
Neutral
A shareholder proposal at Henry Schein (NasdaqGS:HSIC) seeks to implement a simple majority voting standard, which the board opposes. This comes as th...
Bullish
Henry Schein, a major dental and medical products distributor, recently reported its quarterly results, emphasizing margin recovery and operational ef...
Bullish
Henry Schein, a major distributor of dental and medical products, recently reported its quarterly results, which highlighted stable demand in core den...
Henry Schein (HSIC) is currently trading at a discount to its estimated intrinsic value and analyst targets despite solid Q1 results and reaffirmed gu...
Henry Schein (NASDAQ:HSIC) insider William Daniel recently doubled his holdings by purchasing US$692k worth of stock at US$69.19 per share. While this...
Bullish
Henry Schein reported modest Q1 2026 revenue growth and raised its full-year outlook, driven by resilient demand in dental and medical markets. The co...
Neutral
Henry Schein, Inc. shares fell 5.5% despite reporting an 8.1% EPS beat, with statutory profit of US$0.92 per share exceeding expectations. Analysts ha...
Henry Schein (NASDAQ: HSIC) reported strong financial results for Q1 2026, with net sales increasing by 6.3% to $3.37 billion and non-GAAP diluted EPS...
Bullish
Henry Schein, Inc. reported strong first-quarter 2026 financial results, with total net sales increasing by 6.3% to $3.4 billion and non-GAAP diluted ...
Bullish
Henry Schein, Inc. announced its participation in two investor conferences in May: the Bank of America Healthcare Conference on May 13th and the Stife...
Neutral
Henry Schein, Inc. (Nasdaq: HSIC) announced its participation in two investor conferences in May: the Bank of America Healthcare Conference on May 13 ...